AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

British pharmaceutical giant AstraZeneca on Thursday said net profit jumped 18 percent in 2024, boosted by a strong performance from its cancer medicine sales and despite the group's troubles in China ...

AstraZeneca (NASDAQ:AZN) shares gained in European trading on Thursday after the Anglo-Swedish drugmaker reported better-than-expected Q4 2024 results and addressed investor concerns over an ...

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

AstraZeneca on Thursday warned that it could be fined millions of dollars in importation tax fines as Chinese authorities ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super Bowl ...

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

The Monetary Policy Committee, which consists of three RBI and three external members, cut the repo rate by 25 basis points, ...

The company reported net sales of $8.97 billion in fiscal 2024, a 12.1 percent increase from $8.0 billion in prior year.

A fine of between one and five times the unpaid tax of $900,000 could be levied if the company is found liable ...